Article citationsMore>>

V. Murgia, O. Caffo, R. Sorio, C. Griso, A. Scalone, A. Ferro, et al., “Gemcitabine (G) and Epirubicin (E) Combination, in Platinum-Resistant or Refractory Advanced Ovarian Cancer (PROC) Patients: Results of a Multicentric Phase II Trial,” Journal of Clinical Oncology, Vol. 26, No. 15, 2008, p. 5566.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top